India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
Construction of the plant will commence in 2025 with first production expected to be in 2027
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Automated parallel capillary electrophoresis system simplifies protein analysis
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Subscribe To Our Newsletter & Stay Updated
